<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE294nnn/GSE294111/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294111</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>A post-translational regulatory map of chronic antigen-driven human T cell dysfunction</name><description>T cells exposed to persistent antigen, either in the context of chronic viral infections or tumors, iteratively lose both self-renewal and cytotoxic capacity. Several transcriptional, epigenetic, and metabolic drivers of this process have been identified. However, the post-transcriptional regulatory mechanisms influencing the proteome of dysfunctional T cells are not well understood. Here we present a time-resolved cysteine reactivity landscape of human T cells during the development of chronic antigen-driven dysfunction. Persistent T cell receptor stimulation of human T cells following activation significantly remodeled the T cell proteome compared with cytokine-mediated expansion, including changes in canonical T cell exhaustion-associated proteins as well as proteins related to mitochondrial function, redox homeostasis, nucleotide metabolism, and cell cycle progression. Exhausted T cells displayed frequent reactivity changes in nucleotide-binding domains across several protein classes that were associated with progressive loss of mitochondrial ATP production and activation of nucleotide salvage. Our comprehensive proteomic resource thus reveals a unique set of post-transcriptional changes as part of an exhausted T cell program and lays the groundwork for novel cysteine-directed therapeutics to enhance cancer immunotherapy.</description><dates><publication>2026/04/15</publication></dates><accession>GSE294111</accession><cross_references><GSM>GSM8898842</GSM><GSM>GSM8898843</GSM><GSM>GSM8898840</GSM><GSM>GSM8898841</GSM><GSM>GSM8898846</GSM><GSM>GSM8898835</GSM><GSM>GSM8898836</GSM><GSM>GSM8898847</GSM><GSM>GSM8898844</GSM><GSM>GSM8898845</GSM><GSM>GSM8898834</GSM><GSM>GSM8898839</GSM><GSM>GSM8898848</GSM><GSM>GSM8898837</GSM><GSM>GSM8898838</GSM><GPL>24676</GPL><GSE>294111</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>